Isis Pharmaceuticals (NASDAQ:ISIS) is one of today's biggest movers, up 3.6% to $18.19. The S&P is currently trading 0.5% higher to 1,557 and the Dow Jones Industrial Average is trading 0.5% higher to 14,525.
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
In the past 52 weeks, shares of Isis Pharmaceuticals have traded between a low of $6.25 and a high of $18.28 and are now at $18.19, which is 191% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 2.9%.
Isis Pharmaceuticals (NASDAQ:ISIS) defies analysts with a current price ($18.19) 24.9% above its average consensus price target of $13.67. The stock should discover initial support at its 50-day moving average (MA) of $14.83 and subsequent support at its 200-day MA of $12.38.